The Bone Morphogenetic Proteins market is projected to grow from USD 542.3 million in 2020 to USD 633.1 million by 2026 at a CAGR of over 2.6% during the forecast period.
North America held a significant market share in 2020 and is projected to grow at a healthy CAGR during the forecast period.